Objective-To investigate further the influence of the autonomic nervous system on chronic rheumatic diseases. Methods-The density and aYnity of 2 adrenergic receptors ( 2R) on CD19+ lymphocytes in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc), as well as intracellular cAMP levels in patients with RA and SLE, were determined. Human peripheral blood mononuclear cells were separated from venous blood of patients and healthy controls by Ficoll-Hypaque density centrifugation. CD19+ lymphocytes were purified by magnetic cell sorting, and 2R were determined by a radioligand binding assay with [ 125 I]iodocyanopindolol. Intracellular cAMP levels and 2R agonist induced cell death were measured by a radioimmunoassay and flow cytometry using annexin-V binding, respectively. Systemic disease activity of the patients was evaluated using multifactorial scoring systems. Results-The density of 2R on peripheral CD19+ lymphocytes was significantly decreased in patients with RA, SLE, and SSc compared with healthy controls. In patients with RA and SSc 2R density was negatively correlated with systemic disease activity. Furthermore, although basal intracellular cAMP levels were raised in patients with RA and SLE, the increase of cAMP upon stimulation of 2R was significantly reduced in these patients compared with control subjects. Preliminary data suggest that 2R agonist induced cell death is diminished in patients with RA exhibiting decreased 2R densities. Conclusions-The results of this study show a reduction of 2R densities on B lymphocytes mirrored by an impaired intracellular cAMP generation in patients with chronic rheumatic diseases, indicating a decreased influence of the autonomic nervous system on B cells in these conditions.